Jun Yoon
Finanzdirektor/CFO bei STRUCTURE THERAPEUTICS INC.
Vermögen: 34 Mio $ am 30.04.2024
Profil
Jun Yoon is currently the Chief Operating Officer & Director at Shanghai ShouTi Biotechnology Co. Ltd.
and the Chief Financial Officer at Structure Therapeutics, Inc. He previously worked as the Senior Director-Licensing & Business Development at VIA Pharmaceuticals, Inc. from 2004 to 2010, the Head-Business Development at Syrrx, Inc. from 2000 to 2002, and the Vice President-Corporate Development at Cellerant Therapeutics, Inc. from 2010 to 2016.
Mr. Yoon obtained his undergraduate degree from the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.04.2024 | 2 620 050 ( 1,87% ) | 34 Mio $ | 30.04.2024 |
Aktive Positionen von Jun Yoon
| Unternehmen | Position | Beginn |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Finanzdirektor/CFO | 01.05.2022 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Jun Yoon
| Unternehmen | Position | Ende |
|---|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Corporate Officer/Principal | 01.01.2016 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2010 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Corporate Officer/Principal | 01.10.2002 |
Ausbildung von Jun Yoon
| University of California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| VIA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
